# OnCo record remarc (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/remarc/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "remarc", "NCT01122472" ;
  schema:name "REMARC"@en ;
  schema:alternateName "Lenalidomide maintenance in elderly diffuse large B-cell lymphoma"@en, "REMARC trial"@en ;
  schema:description "Two years of a tablet taken after chemotherapy delayed relapse in older people with aggressive lymphoma but did not help them live longer, and caused low white cell counts in over half."@en ;
  schema:url <https://onco.cc/trials/remarc/> ;
  schema:dateModified "2026-10-01"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01122472>, <https://doi.org/10.1200/JCO.2017.72.6984> ;
  onco:status "mixed" ;
  onco:tag "lymphoma-evidence" ;
  onco:phase "3" ;
  schema:startDate "2009-04" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/>, <https://onco.cc/fronts/chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/lenalidomide/>, <https://onco.cc/drugs/rituximab/> ;
  onco:companies <https://onco.cc/companies/lysa/> ;
  onco:terms <https://onco.cc/terms/maintenance-therapy/>, <https://onco.cc/terms/lymphoma-tx-maintenance/>, <https://onco.cc/terms/r-chop/>, <https://onco.cc/terms/ipi-score/> ;
  onco:people <https://onco.cc/people/catherine-thieblemont/>, <https://onco.cc/people/gilles-salles/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-toxicity-qol/>, <https://onco.cc/bottlenecks/b-aging-comorbidity/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-remarc-lenalidomide-maintenance-dlbcl-jco-2017/> .